This study investigates OR7A10-engineered CAR-NK cells, showing they enhance tumor-killing ability, persistence, and survival in solid tumor models, offering a scalable cancer therapy.
This study introduces Y-MATRIX, a taxonomy classifying genomic profiling results by clinical actionability, showing increased actionable findings in advanced lung cancer from 2017 to 2023.
This study investigates drug sensitivity in colorectal cancer peritoneal metastases, showing CMS4 tumors respond better to mitomycin-C and irinotecan, informing personalized chemotherapy strategies.
This study investigates how socioeconomic and racial disparities impact access to immunotherapy for triple-negative breast cancer in the U.S., showing equitable access can improve outcomes for marginalized groups.